ESSA Pharma to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
ESSA Pharma Inc. (NASDAQ: EPIX) announced its participation in the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022, at 2:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX) announced its participation in the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022, at 2:30 p.m. ET. The company's President and CEO, David R. Parkinson, will host one-on-one meetings along with COO Peter Virsik and CFO David S. Wood. The event will be held at the Metro Toronto Convention Centre, offering investors insights into the latest developments in the healthcare sector. A webcast of the presentation will be available on ESSA's website and archived for 90 days.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +3.20%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, April 26, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2022 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022 at 2:30 p.m. Eastern Time.
David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.
Presentation Date: | Monday, May 2, 2022 |
Presentation Time: | 2:30 p.m. ET |
Location: | Metro Toronto Convention Centre |
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived for 90 days.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2022-bloom-burton--co-healthcare-investor-conference-301533609.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.